Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes

S Mangmool, P Hemplueksa… - Molecular …, 2015 - academic.oup.com
Molecular endocrinology, 2015academic.oup.com
Although the cardioprotective effects of glucagon-like peptide-1 and its analogs have been
reported, the exact mechanisms of the glucagon-like peptide-1 receptor (GLP-1R) signaling
pathway in the heart are still unclear. Activation of the GLP-1R has been shown to increase
cAMP levels, thus eliciting protein kinase A-and exchange protein activated by cAMP (Epac)-
dependent signaling pathways in pancreatic β-cells. However, which pathway plays an
important role in the antioxidant and antiapoptotic effects of GLP-1R activation in the heart is …
Abstract
Although the cardioprotective effects of glucagon-like peptide-1 and its analogs have been reported, the exact mechanisms of the glucagon-like peptide-1 receptor (GLP-1R) signaling pathway in the heart are still unclear. Activation of the GLP-1R has been shown to increase cAMP levels, thus eliciting protein kinase A- and exchange protein activated by cAMP (Epac)-dependent signaling pathways in pancreatic β-cells. However, which pathway plays an important role in the antioxidant and antiapoptotic effects of GLP-1R activation in the heart is not known. In this study, we demonstrated that stimulation of GLP-1Rs with exendin-4 attenuated H2O2-induced reactive oxygen species production and increased the synthesis of antioxidant enzymes, catalase, glutathione peroxidase-1, and manganese superoxide dismutase that is dependent on Epac. Additionally, exendin-4 has an antiapoptotic effect by decreasing a number of apoptotic cells, inhibiting caspase-3 activity, and enhancing the expression of antiapoptotic protein B-cell lymphoma 2, which is mediated through both protein kinase A- and Epac-dependent pathways. These data indicate a critical role for Epac in GLP-1R-mediated cardioprotection.
Oxford University Press